News and Press Releases

Builds on a shared pedigree of data management, statistics and programming excellence across all phases of clinical trials

SOUTHBOROUGH, MA – February 25, 2021 – Veristat, a scientific-minded global clinical research organization (CRO), announced today the expansion of its biometrics capacities by acquiring SQN Clinical, a market-leader in the healthcare arena and one of the largest data focused specialty contract research companies in Europe. 

Delivering A Patient-Centric Approach to Recruitment and Retention for Clinical Trials

SOUTHBOROUGH, MA – December 7, 2020 –Veristat, a global clinical research organization, was named among the Top Patient Recruitment Companies of 2020 by Pharma Tech Outlook.

Delivering on Customer Demand for Pharmacovigilance
from Clinical Trial Conduct to Post-Marketing Support

SOUTHBOROUGH, MA – October 22, 2020 – Cell and gene therapies represent the next great wave of therapeutic innovation and have led to the development of promising therapies worldwide.

Veristat Enhances Patient-Centricity Offering by Delivering Clinical Trials
Directly to Patients

SOUTHBOROUGH, MA – September 30, 2020 – Veristat, a scientific-minded global clinical research organization (CRO), announced today the launch of a virtual clinical trial solution that is flexible and customizable so that patient interactions can be conducted at the clinical site, remotely at-home, or through a hybrid combination of both strategies.

Increasing Its Footprint and Expanding Therapeutic Expertise to Guide Sponsors Throughout the Clinical Development Lifecycle

Expanding Its Team of Regulatory Experts to Guide Biopharmaceutical Sponsors Along the Pathway to Market Approval

Veristat Expands Operations into Taiwan to Support Growing Client Demand for Clinical Trial, Biostatistics and Programming Excellence in the Region

Opens office in Taipei, Taiwan

Veristat Celebrates Its Support of over 75 Global Regulatory Submissions Since Its Founding